Report Detail
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027
- RnM3951272 |
- 22 March, 2021 |
- Global |
- 185 Pages |
- QYResearch |
- Medical Industry
Gastroesophageal Reflux Disease (GERD) Drugs and Devices market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.
Segment by Type, the Gastroesophageal Reflux Disease (GERD) Drugs and Devices market is segmented into Medication, Minimally Invasive Surgery, Invasive Surgery, etc.
Segment by Application, the Gastroesophageal Reflux Disease (GERD) Drugs and Devices market is segmented into Heartburn, Acid reflux disorders, etc.
Regional and Country-level Analysis
The report offers exhaustive assessment of different region-wise and country-wise Gastroesophageal Reflux Disease (GERD) Drugs and Devices markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.
The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Competitive Landscape and Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis
Gastroesophageal Reflux Disease (GERD) Drugs and Devices market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in Gastroesophageal Reflux Disease (GERD) Drugs and Devices business, the date to enter into the Gastroesophageal Reflux Disease (GERD) Drugs and Devices market, Gastroesophageal Reflux Disease (GERD) Drugs and Devices product introduction, recent developments, etc.
The major vendors include AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB), Pfizer, Inc., Eisai Co. Ltd., The Procter & Gamble Company, Mederi Therapeutics, Aros Pharma, Torax Medical, Inc., BD, EndoGastric Solutions, Medigus Ltd., etc.
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type: 2016 VS 2021 VS 2027
- 1.2.2 Medication
- 1.2.3 Minimally Invasive Surgery
- 1.2.4 Invasive Surgery
- 1.3 Market by Application
- 1.3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application: 2016 VS 2021 VS 2027
- 1.3.2 Heartburn
- 1.3.3 Acid reflux disorders
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trend
- 2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Perspective (2016-2027)
- 2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Growth Trends by Regions
- 2.2.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Regions: 2016 VS 2021 VS 2027
- 2.2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Regions (2016-2021)
- 2.2.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Regions (2022-2027)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Trends
- 2.3.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
- 2.3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
- 2.3.4 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Market Size
- 3.1.1 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue
- 3.1.2 Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Revenue (2016-2021)
- 3.1.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Players (2016-2021)
- 3.1.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio
- 3.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 5 and Top 10 Players by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2020
- 3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Players Head office and Area Served
- 3.4 Key Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Solution and Service
- 3.5 Date of Enter into Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Type (2016-2027)
- 4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Type (2016-2021)
- 4.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Type (2022-2027)
5 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Application (2016-2027)
- 5.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Application (2016-2021)
- 5.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Application (2022-2027)
6 North America
- 6.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 6.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in North America (2020-2021)
- 6.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
- 6.3.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2016-2021)
- 6.3.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2022-2027)
- 6.4 U.S. Market Size Analysis
- 6.4.1 U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 6.4.2 U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 6.4.3 U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 6.5 Canada Market Size Analysis
- 6.5.1 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 6.5.2 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 6.5.3 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
7 Europe
- 7.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 7.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in Europe (2020-2021)
- 7.3 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
- 7.3.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2016-2021)
- 7.3.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2022-2027)
- 7.4 Germany Market Size Analysis
- 7.4.1 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 7.4.2 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 7.4.3 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 7.5 France Market Size Analysis
- 7.5.1 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 7.5.2 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 7.5.3 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 7.6 U.K. Market Size Analysis
- 7.6.1 U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 7.6.2 U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 7.6.3 U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 7.7 Italy Market Size Analysis
- 7.7.1 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 7.7.2 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 7.7.3 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 7.8 Russia Market Size Analysis
- 7.8.1 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 7.8.2 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 7.8.3 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
8 Asia-Pacific
- 8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in Asia-Pacific (2020-2021)
- 8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
- 8.3.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2016-2021)
- 8.3.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2022-2027)
- 8.4 China Market Size Analysis
- 8.4.1 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.4.2 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.4.3 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.5 Japan Market Size Analysis
- 8.5.1 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.5.2 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.5.3 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.6 South Korea Market Size Analysis
- 8.6.1 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.6.2 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.6.3 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.7 India Market Size Analysis
- 8.7.1 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.7.2 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.7.3 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.8 Australia Market Size Analysis
- 8.8.1 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.8.2 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.8.3 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.9 Taiwan Market Size Analysis
- 8.9.1 Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.9.2 Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.9.3 Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.10 Indonesia Market Size Analysis
- 8.10.1 Indonesia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.10.2 Indonesia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.10.3 Indonesia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.11 Thailand Market Size Analysis
- 8.11.1 Thailand Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.11.2 Thailand Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.11.3 Thailand Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.12 Malaysia Market Size Analysis
- 8.12.1 Malaysia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.12.2 Malaysia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.12.3 Malaysia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.13 Philippines Market Size Analysis
- 8.13.1 Philippines Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.13.2 Philippines Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.13.3 Philippines Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 8.14 Vietnam Market Size Analysis
- 8.14.1 Vietnam Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 8.14.2 Vietnam Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 8.14.3 Vietnam Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
9 Latin America
- 9.1 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 9.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in Latin America (2020-2021)
- 9.3 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
- 9.3.1 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2016-2021)
- 9.3.2 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2022-2027)
- 9.4 Mexico Market Size Analysis
- 9.4.1 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 9.4.2 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 9.4.3 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 9.5 Brazil Market Size Analysis
- 9.5.1 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 9.5.2 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 9.5.3 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 9.6 Argentina Market Size Analysis
- 9.6.1 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 9.6.2 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 9.6.3 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
10 Middle East & Africa
- 10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 10.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in Middle East & Africa (2020-2021)
- 10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
- 10.3.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2016-2021)
- 10.3.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2022-2027)
- 10.4 Turkey Market Size Analysis
- 10.4.1 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 10.4.2 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 10.4.3 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 10.5 Saudi Arabia Market Size Analysis
- 10.5.1 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 10.5.2 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 10.5.3 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
- 10.6 UAE Market Size Analysis
- 10.6.1 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
- 10.6.2 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
- 10.6.3 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027)
11 Key Players Profiles
- 11.1 AstraZeneca, Plc.
- 11.1.1 AstraZeneca, Plc. Company Details
- 11.1.2 AstraZeneca, Plc. Business Overview and Its Total Revenue
- 11.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.1.4 AstraZeneca, Plc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.1.5 AstraZeneca, Plc. Recent Development
- 11.2 Addex Therapeutics
- 11.2.1 Addex Therapeutics Company Details
- 11.2.2 Addex Therapeutics Business Overview and Its Total Revenue
- 11.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.2.4 Addex Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.2.5 Addex Therapeutics Recent Development
- 11.3 Takeda Pharmaceutical Company Limited
- 11.3.1 Takeda Pharmaceutical Company Limited Company Details
- 11.3.2 Takeda Pharmaceutical Company Limited Business Overview and Its Total Revenue
- 11.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.3.4 Takeda Pharmaceutical Company Limited Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.3.5 Takeda Pharmaceutical Company Limited Recent Development
- 11.4 Rottapharm (Meda AB)
- 11.4.1 Rottapharm (Meda AB) Company Details
- 11.4.2 Rottapharm (Meda AB) Business Overview and Its Total Revenue
- 11.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.4.4 Rottapharm (Meda AB) Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.4.5 Rottapharm (Meda AB) Recent Development
- 11.5 Pfizer, Inc.
- 11.5.1 Pfizer, Inc. Company Details
- 11.5.2 Pfizer, Inc. Business Overview and Its Total Revenue
- 11.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.5.4 Pfizer, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.5.5 Pfizer, Inc. Recent Development
- 11.6 Eisai Co. Ltd.
- 11.6.1 Eisai Co. Ltd. Company Details
- 11.6.2 Eisai Co. Ltd. Business Overview and Its Total Revenue
- 11.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.6.4 Eisai Co. Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.6.5 Eisai Co. Ltd. Recent Development
- 11.7 The Procter & Gamble Company
- 11.7.1 The Procter & Gamble Company Company Details
- 11.7.2 The Procter & Gamble Company Business Overview and Its Total Revenue
- 11.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.7.4 The Procter & Gamble Company Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.7.5 The Procter & Gamble Company Recent Development
- 11.8 Mederi Therapeutics
- 11.8.1 Mederi Therapeutics Company Details
- 11.8.2 Mederi Therapeutics Business Overview and Its Total Revenue
- 11.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.8.4 Mederi Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.8.5 Mederi Therapeutics Recent Development
- 11.9 Aros Pharma
- 11.9.1 Aros Pharma Company Details
- 11.9.2 Aros Pharma Business Overview and Its Total Revenue
- 11.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.9.4 Aros Pharma Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.9.5 Aros Pharma Recent Development
- 11.10 Torax Medical, Inc.
- 11.10.1 Torax Medical, Inc. Company Details
- 11.10.2 Torax Medical, Inc. Business Overview and Its Total Revenue
- 11.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.10.4 Torax Medical, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.10.5 Torax Medical, Inc. Recent Development
- 11.11 BD
- 11.11.1 BD Company Details
- 11.11.2 BD Business Overview and Its Total Revenue
- 11.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.11.4 BD Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.11.5 BD Recent Development
- 11.12 EndoGastric Solutions
- 11.12.1 EndoGastric Solutions Company Details
- 11.12.2 EndoGastric Solutions Business Overview and Its Total Revenue
- 11.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.12.4 EndoGastric Solutions Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.12.5 EndoGastric Solutions Recent Development
- 11.13 Medigus Ltd.
- 11.13.1 Medigus Ltd. Company Details
- 11.13.2 Medigus Ltd. Business Overview and Its Total Revenue
- 11.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
- 11.13.4 Medigus Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
- 11.13.5 Medigus Ltd. Recent Development
12 Analyst's Viewpoints/Conclusion
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
Summary:
Get latest Market Research Reports on Gastroesophageal Reflux Disease (GERD) Drugs and Devices. Industry analysis & Market Report on Gastroesophageal Reflux Disease (GERD) Drugs and Devices is a syndicated market report, published as Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027. It is complete Research Study and Industry Analysis of Gastroesophageal Reflux Disease (GERD) Drugs and Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
